Extended Analysis for Leukemia/Lymphoma Treatment
NCT03096821
·
clinicaltrials.gov ↗
COMPLETED
Status
143
Enrollment
OTHER
Sponsor class
Conditions
Relapsed Hematologic Malignancy
Interventions
DRUG:
ngFDS selected treatment
Sponsor
Medical University of Vienna